Hills Bank & Trust Co increased its holdings in shares of Manhattan Associates, Inc. (NASDAQ:MANH – Free Report) by 34.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 2,194 shares of the software maker’s stock after purchasing an additional 568 shares during the quarter. Hills Bank & Trust Co’s holdings in Manhattan Associates were worth $380,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Twin Tree Management LP acquired a new position in shares of Manhattan Associates in the 4th quarter valued at $25,000. Whipplewood Advisors LLC purchased a new position in shares of Manhattan Associates in the 4th quarter worth $34,000. Park Square Financial Group LLC acquired a new position in Manhattan Associates in the fourth quarter valued at $38,000. Transce3nd LLC purchased a new stake in Manhattan Associates during the fourth quarter valued at about $41,000. Finally, Central Pacific Bank Trust Division grew its position in Manhattan Associates by 107.3% during the first quarter. Central Pacific Bank Trust Division now owns 199 shares of the software maker’s stock valued at $34,000 after acquiring an additional 103 shares during the period. 98.45% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the company. DA Davidson lifted their price objective on Manhattan Associates from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, May 21st. Loop Capital restated a “hold” rating and issued a $170.00 price target (down previously from $275.00) on shares of Manhattan Associates in a report on Thursday, April 10th. Piper Sandler decreased their price objective on shares of Manhattan Associates from $268.00 to $200.00 and set an “overweight” rating for the company in a research note on Friday, March 14th. Redburn Atlantic lowered shares of Manhattan Associates from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $270.00 to $200.00 in a research report on Tuesday, June 10th. Finally, Truist Financial lifted their target price on shares of Manhattan Associates from $190.00 to $210.00 and gave the company a “buy” rating in a report on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Manhattan Associates currently has an average rating of “Moderate Buy” and a consensus price target of $208.88.
Manhattan Associates Stock Up 1.6%
MANH opened at $197.25 on Monday. The firm’s 50 day moving average is $186.76 and its 200-day moving average is $203.39. Manhattan Associates, Inc. has a 52-week low of $140.81 and a 52-week high of $312.60. The firm has a market capitalization of $11.98 billion, a P/E ratio of 56.36 and a beta of 1.08.
About Manhattan Associates
Manhattan Associates, Inc develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations. It offers Warehouse Management Solution for managing goods and information across the distribution centers; Manhattan Active Warehouse Management, a cloud native and version less application for the associate; and Transportation Management Solution for helping shippers navigate their way through the demands and meet customer service expectations at the lowest possible freight costs; Manhattan SCALE, a portfolio of logistics execution solution; and Manhattan Active Omni, which offers order management, store inventory and fulfillment, POS, and customer engagement tools for enterprises and stores.
See Also
- Five stocks we like better than Manhattan Associates
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- AutoNation: Growth Engines Make It an Undervalued Stock
- 3 Dividend Kings To Consider
- Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Want to see what other hedge funds are holding MANH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Manhattan Associates, Inc. (NASDAQ:MANH – Free Report).
Receive News & Ratings for Manhattan Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manhattan Associates and related companies with MarketBeat.com's FREE daily email newsletter.